Test Offered by Solstas for Improved Cardiovascular Care: NT-proBNP (10/22/12)

Solstas Lab Partners is pleased to announce the addition of NT-proBNP (Brain Natriuretic Peptide) to our clinical testing menu. NT-proBNP may provide additional clinical information in the diagnosis and evaluation of patients suspected of having congestive heart failure. NT-proBNP has also been described in the risk stratification of patients with acute coronary syndrome and as an aid in the assessment of increased risk of cardiovascular events and mortality in patients at risk for heart failure who have stable coronary artery disease.

Please read the tech bulletin here: Test Offered by Solstas for Improved Cardiovascular Care: NT-proBNP